Insider Trading June 15, 2026 04:05 PM

Embank Bancorp Director Executes Share Purchase Amid Capital Return Strategy

John T. Yurconic acquires 500 shares as the bank expands its stock repurchase program and trades near 52-week highs.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn

Embassy Bancorp, Inc. (NASDAQ: EMBY) director John T. Yurconic acquired 500 shares of common stock on June 15, 2026, at $21.45 per share, totaling $10,725. The purchase brings his total holdings to 61,317.447 shares. The transaction was reported via a Form 4 filing signed by Laura A. Suplee under Power of Attorney. Concurrently, the company's board authorized an additional $5 million stock buyback, expanding its initial $5 million program which had $144,000 remaining. The stock trades near its 52-week high of $21.50, following a 40% annual gain, and maintains a 2.24% dividend yield.

Embank Bancorp Director Executes Share Purchase Amid Capital Return Strategy
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director John T. Yurconic purchased 500 shares at $21.45 per share on June 15, 2026, bringing his total holdings to 61,317.447 shares.
  • Embassy Bancorp's board authorized an additional $5 million stock buyback, expanding the initial $5 million program which had $144,000 remaining.
  • The stock trades near its 52-week high of $21.50, following a 40% annual gain, and maintains a 2.24% dividend yield.

Embassy Bancorp, Inc. (NASDAQ: EMBY) has seen continued insider activity as director John T. Yurconic completed a share purchase on June 15, 2026. According to a Form 4 filing submitted to the Securities and Exchange Commission, Yurconic acquired 500 shares of the bank's common stock at a price of $21.45 per share, resulting in a total transaction value of $10,725. The filing, which was signed by Laura A. Suplee on behalf of Yurconic under a Power of Attorney, confirms the direct acquisition.

Following this transaction, Yurconic's total ownership in Embassy Bancorp stands at 61,317.447 shares. The purchase occurs as the stock trades near its 52-week high of $21.50, a level reached after a robust 40% gain over the past year. Market analysis from InvestingPro indicates that the stock remains slightly undervalued at current levels, supported by an attractive 2.24% dividend yield. Subscribers to the platform have access to seven additional exclusive tips regarding EMBY's financial health and growth prospects.

In parallel with the insider purchase, Embassy Bancorp's Board of Directors has authorized an additional $5 million stock buyback. This decision expands the company's existing stock repurchase program, which was initially established with a $5 million limit. Announced in October 2025, the original program facilitated the repurchase of 258,301 shares, totaling $4.856 million by the end of the first quarter of 2026. According to the company's quarterly report filed with the U.S. Securities and Exchange Commission, only $144,000 remained from the initial authorization. The new authorization aims to continue the company's strategy of returning value to shareholders through stock repurchases, reflecting Embassy Bancorp's ongoing commitment to managing its capital effectively.

Risks

  • The stock trades near its 52-week high of $21.50, which may indicate a potential valuation ceiling.
  • Only $144,000 remained from the initial $5 million buyback authorization, suggesting limited capacity for further repurchases under the original program.

More from Insider Trading

Alignment Healthcare Executive Disposes of Shares Under Pre-Arranged Trading Plan Jun 15, 2026 Silver Lake Affiliates Divest $12.1 Million in Dell Technologies Equity Jun 15, 2026 Silver Lake and Director Egon Durban Offload Dell Technologies Shares Worth $460k Jun 15, 2026 Silver Lake Entities Linked to Dell Director Egon Durban Execute $23.7M Share Sale Jun 15, 2026 CervoMed Director Joshua Boger Expands Stake in $2.99M Private Placement Jun 15, 2026